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Summary Rat mamary tumour cells were grafted to parietal bones as an experimental model to study the
nature of bone resorption around metastatic carcinomas in the skeleton. After periods of growth of from 6 to
56 days bones and tumours were removed and embedded in epoxy resin. The appearances were compared
with those found when whole parathyroid glands were grafted in similar positions. Tumours were evident in
all animals at the time of death and some were palpable five days after grafting. In 15 of the 21 animals with
tumour, osteoclasts and resorption were found, and in only two of these were the tumour cells not separated
from the bone surfaces. In 6 animals killed between 6 and 12 days after grafting there was new bone
formation without resorption. There were osteoclasts and resorption under the grafted parathyroid glands
which were always separated from the resorbing cells by fibrous tissue. The appearances of the bone surfaces
under the tumours and the parathyroid glands suggested that the resorption in both situations was similar,
was brought about by the secretion of a locally active agent and mediated by osteoclasts. This is further
support for the role of osteoclasts in bone resorption around metastatic carcinomas.
The skeleton is a common site for metastases of
carcinomas of the mammary, prostate and thyroid
glands. It has been claimed that over 80% of
women with mammary carcinoma have bone
metastases (Jaffe, 1958) and these are often
associated with resorption. There are conflicting
ideas about the way this resorption is brought
about. Older reports (Milch & Changus, 1956)
considered resorption to be largely independent of
osteoclasts. There is a greater tendency now to
accept the role of osteoclasts as being important
(Teitelbaum, 1978 unpublished; Carter & Pittam,
1980; Sissons, 1980; Tsao et al., 1981) but the view
is still held that the malignant cells themselves can
resorb bone (Eilon & Mundy, 1978; Galasko et al.,
1979; Carter et al., 1983).
As part of a broader study of the breakdown of
both mineralized and unmineralized connective
tissue matrices (O'Grady et al., 1981, 1982), we
have used an experimental model to examine the
bone resorption associated with the growth of
transplanted malignant tumours on the parietal
bones of rats and compared it with that caused by
autografts of parathyroid glands in similar
positions (Barnicot, 1948; Chang, t951). The
tumours were produced by injecting into the
parietal periosteum cultured neoplastic cells, derived
from rat mammary carcinomas.
Materials and methods
Grafting
Tumours The primary tumours used in these
experiments arose spontaneously in the mammary
glands of three DA rats of an inbred strain
(Festing, 1980) maintained in the Department of
Pathology, University of Sydney. After a number of
transplantations, neoplastic cell lines were
established and maintained as described previously
(O'Grady et al., 1981, 1982). Both cultured cells
and fragments of the original tumours were stored
in liquid nitrogen. After the percutaneous injection
into the parietal periosteum of 106 cultured
neoplastic cells, suspended in PBS tumours grew on
the surfaces of the parietal bones of syngeneic rats
weighing 100-150g. The rats were killed at
intervals of from 6 to 56 days after these injections.
Parathyroid glands Parathyroid glands were
dissected free of thyroid tissue with the aid of a
binocular microscope and were autografted whole
through a skin incision under the periosteum of the
parietal bones of 12 rats weighing 80-150g. The
animals were killed at intervals of from 5-10 days
after grafting.
Processing
The parietal bones of 21 rats with their attached
tumour transplants, were fixed in 3%
glutaraldehyde in 0.1 M cacodylate buffer either by
immersion of the excised tissue or by perfusion of
the whole animal. Tissues were "post-fixed" in
OS04 and embedded in epoxy resin. Sections (0.5-
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1.0gm) were stained with toluidine blue and basic
fuchsin. The gland grafts and underlying bones
were fixed by perfusion and similarly processed.
Results
Tumour grafts
Tumour nodules were evident macroscopically in all
animals at the time of death and were palpable in
some animals as early as 5 days after injection of
the cells. The bone under three tumours was
almost, if not completely, perforated. In one animal
the bone was perforated in 15 days.
Histological examination showed osteoclasts and
bone resorption (Figure 1) under the tumours in 15
rats, the earliest 11 days after grafting. In 11, the
osteoclasts and the area of resorption were
separated from the tumour cells by a considerable
band of fibrous tissue (Figure 2). In two rats the
osteoclasts and bone had only a thin layer of non-
tumour cells between them and the tumour cells
(Figure 3) and in two others both osteoclasts and
tumour cells were in contact with the bone surface
(Figure 4).
In 6 rats with tumour transplants of up to 12
days duration there was new bone formation
without any resorption of the original bone. In
three, after longer periods of growth, newly formed
bone was present in association with resorption.
Parathyroid grafts
Most of the grafts survived well and in one only
was there considerable lipid in the parenchymal
cells. These grafts were of whole organs and not
suspensions of cells as was the case with the
tumours.
Bone resorption was evident under the glands
after 5 days, with deep penetration after eight days.
Complete perforation was seen in seven rats
between nine and twelve days. The bone surface in
the crater under the gland was usually covered with
osteoclasts (Figure 5), although there were also
some osteoblasts present in three rats. The
parathyroid tissue was not in contact with the bone
surface of the osteoclasts but separated from them
by a layer of fibrous tissue.
Discussion
Various mechanisms have been proposed to explain
bone resorption associated with tumours.
Some observers have noted osteolysis by tumours
ostensibly in the presence of very few osteoclasts or
in their complete absence (Jaffe, 1958; Milch &
Changus, 1958; Shivas et al., 1963) and have
postulated the elaboration of osteolytic substances
by tumour cells. This may have occurred but the
observations are based on paraffin embedded
material. The thickness of the sections and the
distortion of the tissue by the method ofprocessing,
makes interpretation difficult and it is not possible
to identify cells with the certainty that pertains in
thinner sections of tissue embedded in epoxy resins.
A number of authors have proposed a sequence
of supposed events during the resorptive process. It
is claimed that, although osteoclasts are responsible
for osteolysis early in the establishment of a skeletal
metastasis, once the growing tumour has progressed
sufficiently, osteoclasts disappear and tumour cells
become directly responsible for continuing bone
destruction (Hulth & Olerud, 1965; Galasko, 1976;
Carter et al., 1983). These authors infer that,
because osteoclasts cannot be found on bone
surfaces adjacent to the tumours, but are replaced
by tumour cells, the tumour cells are resorbing the
bone. It would be equally valid to infer that,
because the osteoclasts are no longer there,
resorption has ceased. None of these authors
provides data to support the claim that the tumour
cells function as bone resorbers or that resorption
continues in the absence of osteoclasts. They claim
to see a sequence of events but actually describe a
sequence of morphological appearances. They
cannot determine by histological means alone
something that is a functional activity. As Sissons
(1980) points out, where osteoclasts are absent they
may have produced resorption and subsequently
been replaced by tumour cells. This is also inferred
by Faccini (1974).
Nevertheless, it is possible that masses of tumour
cells, completely surrounding spicules of bone,
could bring about a lowering of pH necessary for
the first step in bone resorption, that is, dissolution
of the mineral component (Neuman et al., 1960).
The cell lines we have used, synthesize and secrete
collagenase and plasminogen activator (O'Grady et
al., 1981, 1982) and it is likely that they can
produce other hydrolytic enzymes that are capable
of breaking down other matrix components after
demineralization. Some in vitro studies (Eilon &
Mundy, 1978) have indicated that human breast
carcinoma cells could cause the release of labelled
calcium and hydroxyproline from cultured bones
whether the bones were living or devitalized. Media
in which the carcinoma cells had been growing had
a similar effect. The system used was an artificial
one and Eilon & Mundy agreed that their
experiments did not preclude osteoclastic action in
vivo.
Whereas osteoclasts are rare on the outer surface
of the normal rat parietal bone, we found thema
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Figure 2 Both resorption (r) and new bone formation (n) adjacent to a tumour 12 days after transplantation.
The islands of tumour cells (t) are separated from the parietal bone by a wide band of fibrous tissue. (x 160).
Figure 3 Osteoclasts (o) lining a resorption cavity 26 days after transplantation and separated from the
tumour by a few flattened cells (arrow). The attenuated cytoplasmic extensions of osteoclasts, although
recognizable here because of their numerous mitochondria, would be difficult to detect in tissue embedded in
paraffin. (x950).OSTEOCLASTS AND RESORPTION OF BONE BY MAMMARY CARCINOMAS 771
a
Figure 4 (a) Tumour cells (t) 21 days after transplantation, directly in contact with osteoclasts and bone.
( x 225). (b) Osteoclasts at the interface in (a) between the invading tumour and bone. ( x 800).772 R.L. O'GRADY & D.A. CAMERON
a
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Figure 5 (a) Resorption beneath a 10 day old parathyroid gland autograft. The cavity is lined by osteoclasts
(o) which are separated from the graft (p) by a layer of fibrous tissue. The depth of the resorption cavity is
shown with arrowheads. ( x 225). (b) Osteoclasts lining part of the cavity in (a). ( x 500).OSTEOCLASTS AND RESORPTION OF BONE BY MAMMARY CARCINOMAS 773
present in considerable numbers adjacent to well
established tumour transplants, congregated in
areas of resorption. Osteoclastic action has become
much more complicated than appeared 15 years or
so ago. Not only are the cells thought to be part of
the macrophage family (Gothlin & Ericsson, 1973)
but they respond to an increasing number of
chemical agents in addition to the archetypal
parathyroid hormone (PTH). Some of these,
including PTH, have been shown to be produced by
tumours e.g. Vitamin D-related substances,
osteoclast activating factor (OAF) Mundy et al.,
1974), prostaglandins (PGs) and growth factors
(Tashjian, 1981). Like PTH, they possibly all affect
osteoclasts indirectly through osteoblasts (O'Grady
& Cameron, 1972; Rodan & Martin, 1981; Silve et
al., 1982) (or perhaps other cells) and of them all,
PGs and growth factors are likely candidates in
mammary tumour bone metastases. Various
metabolites of arachidonic acid are potent
stimulators of bone resorption and these are
produced by tumour, bone and other cells. (Raisz
et al., 1974; Seyberth, 1978; Dominguez & Mundy,
1980).
Bone remodelling responds readily to stress, and
pressure causes resorption (Storey & Feik, 1982;
Pollard et al., 1984). It has been proposed that
"pressure atrophy" (Shivas et al., 1963) leading to
necrosis, or "growth pressure" cause resorption
(Jaffe, 1958) but no explanation has been offered as
to just how the mineralized tissue was removed,
although osteoclasts were said not to be involved.
In our experiments resorption took a few days to
become apparent during which time any pressure
differences resulting from the injection of the cells
should have been dissipated quickly. Any pressure
as the tumour mass increased in size would have
been equalized by changes in the very loose areolar
tissue below the freely movable skin. Newly formed
bone was conspicuous under the short term grafts
and the trau;na of injection may have contributed
to its formation. New bone formation is often
found with secondary carcinomas (Willis, 1952;
Jaffe, 1958) and can be easily recognised
histologically even when covered by tumour cells. It
is interesting that the tumour cells themselves have
never been accused of laying down this new bone.
While conceding that resorption in the parietal
bones could have been the result of pressure, the
results reported here show that their morphological
appearances closely resemble those found when a
parathyroid gland is transplanted to periosteum.
This technique was first used over 30 years ago as
part of the experimental demonstration of the effect
of PTH, when Barnicot (1948) and Chang (1951)
found that parathyroid grafts produced rapid
osteoclastic resorption, whereas grafts of a variety
of other tissues had insignificant effects. It
prompted us to use the same approach with
tumours. Like most of the tumour transplants, the
parathyroid glands were separated from the
localised resorption areas by mesenchymal tissue
and the resorption cavities had many more
osteoclasts than were found on undisturbed bone
surfaces. Given the known role of osteoclasts in
resorption and the relationship of PTH from the
gland transplant to Qesteoclast activity, it seems
logical to presume that the resorption under the
tumour transplants was mediated by osteoclast-
activating chemical agents from the tumour. These
could have been, for example, prostaglandins
produced by the malignant cells, growth factors
specified by their oncogenes or a combination of
both.
We conclude that, in our in vivo experimental
model, the bone resorption under these mammary
tumours was brought about by osteoclasts. It still
remains to be demonstrated if resorption continues
in the absence of osteoclasts and if neoplastic or
other cells in metastatic tumours have the capacity
to break down bone matrix.
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